Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2007-03-01 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PONTARLIER (25300), Doubs
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELURL PHARMACIE SAINT BENIGNE : revenue, balance sheet and financial ratios
SELURL PHARMACIE SAINT BENIGNE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PONTARLIER (25300),
this company of category PME
shows in 2025 a net income positive of 56 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE SAINT BENIGNE (SIREN 494748155)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
56 387 €
-492 €
150 302 €
59 764 €
47 757 €
66 630 €
57 225 €
76 714 €
86 925 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELURL PHARMACIE SAINT BENIGNE generates positive net income of 56 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 87 k€ -> 56 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
56 387 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 32%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
32.327%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.158%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELURL PHARMACIE SAINT BENIGNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
123.617
96.236
72.904
55.45
57.346
44.046
24.005
32.88
32.327
Financial autonomy
40.439
46.449
53.056
57.423
58.023
63.99
72.548
66.841
68.158
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
32.332025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good+11 pts over 3 years
In 2025, the debt ratio of SELURL PHARMACIE SAINT BE... (32.33) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
68.16%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good-5 pts over 3 years
In 2025, the financial autonomy of SELURL PHARMACIE SAINT BE... (68.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 335.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
335.001
Liquidity indicators evolution SELURL PHARMACIE SAINT BENIGNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
158.822
159.552
170.604
158.313
288.339
427.881
356.632
303.213
335.001
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
335.02025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of SELURL PHARMACIE SAINT BE... (335.00) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELURL PHARMACIE SAINT BENIGNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELURL PHARMACIE SAINT BENIGNE is estimated at
895 714 €
(range 607 835€ - 1 405 498€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
607k€895k€1405k€
895 714 €Range: 607 835€ - 1 405 498€
NAF 5 année 2025
Valuation method used
Net Income Multiple
56 387 €
×
15.9x
=895 714 €
Range: 607 836€ - 1 405 499€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE SAINT BENIGNE with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE SAINT BENIGNE
What is the revenue of SELURL PHARMACIE SAINT BENIGNE ?
The revenue of SELURL PHARMACIE SAINT BENIGNE is not publicly disclosed (confidential accounts filed with INPI).
Is SELURL PHARMACIE SAINT BENIGNE profitable?
Yes, SELURL PHARMACIE SAINT BENIGNE generated a net profit of 56 k€ in 2025.
Where is the headquarters of SELURL PHARMACIE SAINT BENIGNE ?
The headquarters of SELURL PHARMACIE SAINT BENIGNE is located in PONTARLIER (25300), in the department Doubs.
Where to find the tax return of SELURL PHARMACIE SAINT BENIGNE ?
The tax return of SELURL PHARMACIE SAINT BENIGNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE SAINT BENIGNE operate?
SELURL PHARMACIE SAINT BENIGNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart